van Zijl N L F, Janson J T, Sussman M, Geldenhuys A
Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Netcare Milpark Hospital, Johannesburg, South Africa.
Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e211. doi: 10.7196/AJTCCM.2023.v29i4.211. eCollection 2023.
Extracorporeal membrane oxygenation (ECMO) is an advanced, resource-intensive technology used in a limited capacity in South Africa (SA). Minimal data on the use of ECMO in SA are available.
To describe the indications, early outcome and comorbidities of patients placed on ECMO in the highest-volume ECMO centre in SA.
We performed a single-centre retrospective review of all adult patients supported with any form of ECMO from August 2016 to December 2018. Operative and clinical records were reviewed. The primary objective of this study was to review the outcome of patients placed on ECMO in the form of survival to hospital discharge. The secondary objectives were to identify population-specific comorbidities and indications for ECMO that could be associated with non-survival and to compare outcome with known risk scores in the form of the Respiratory ECMO Survival Prediction (RESP) and Survival After Venoarterial ECMO (SAVE) scores.
One hundred and seven patients were identified. The primary indication for ECMO was respiratory support in 78 patients and cardiac support in 29 patients. Forty-seven patients were discharged from hospital, with a 44.0% overall survival rate. Gender (p=0.039), age (p=0.019) and hypertension (p=0.022) were associated with death in univariate logistic regression analysis. However, after adjusting for potential confounding in multivariate logistic regression analysis, the association was no longer significant. In the all respiratory support group, patients in risk class IV had better than predicted survival according to the RESP score, while risk classes I, II and III had worse than predicted survival. In the circulatory support group, all risk classes had worse than predicted survival according to the SAVE score.
We report ECMO outcomes in SA for the first time. We identified very high mortality rates for patients transferred on ECMO from other facilities and for patients converted from venovenous ECMO to venoarterial ECMO. Although our outcomes were comparable in some of the risk classes, further external validation of the SAVE and RESP scores will be needed to compare our outcomes with these scores.
We report on extracorporeal membrane oxygenation (ECMO) outcomes in South Africa for the first time. We identified a high mortality rate in patients transferred on ECMO from other facilities, and in patients converted from venovenous ECMO to venoarterial ECMO. Transferred patients had a high mortality rate. The reason for this should be further investigated and may highlight the need for possible protocols to assist with appropriate timing of patient transfers and possible earlier intervention or transfer.
体外膜肺氧合(ECMO)是一项先进的、资源密集型技术,在南非(SA)的应用范围有限。关于南非ECMO使用情况的数据极少。
描述南非最大规模ECMO中心接受ECMO治疗的患者的适应症、早期结局和合并症。
我们对2016年8月至2018年12月期间接受任何形式ECMO支持的所有成年患者进行了单中心回顾性研究。查阅了手术和临床记录。本研究的主要目的是回顾以出院存活为形式的接受ECMO治疗患者的结局。次要目的是确定可能与非存活相关的特定人群合并症和ECMO适应症,并以呼吸ECMO生存预测(RESP)和静脉-动脉ECMO后生存(SAVE)评分的形式将结局与已知风险评分进行比较。
共确定107例患者。ECMO的主要适应症是78例患者的呼吸支持和29例患者的心脏支持。47例患者出院,总体生存率为44.0%。单因素逻辑回归分析显示,性别(p=0.039)、年龄(p=0.019)和高血压(p=0.022)与死亡相关。然而,在多因素逻辑回归分析中对潜在混杂因素进行校正后,这种关联不再显著。在所有呼吸支持组中,根据RESP评分,IV级风险患者的生存情况优于预测,而I、II和III级风险患者的生存情况则比预测的差。在循环支持组中,根据SAVE评分,所有风险级别的患者生存情况均比预测的差。
我们首次报告了南非的ECMO治疗结局。我们发现,从其他机构转来接受ECMO治疗的患者以及从静脉-静脉ECMO转为静脉-动脉ECMO的患者死亡率非常高。尽管我们在某些风险级别中的结局具有可比性,但仍需要对SAVE和RESP评分进行进一步的外部验证,以便将我们的结局与这些评分进行比较。
我们首次报告了南非的体外膜肺氧合(ECMO)治疗结局。我们发现,从其他机构转来接受ECMO治疗的患者以及从静脉-静脉ECMO转为静脉-动脉ECMO的患者死亡率很高。转来的患者死亡率高。对此原因应进一步调查,这可能凸显了制定可能方案以协助确定患者转运的合适时机以及可能进行更早干预或转运的必要性。